Name | tert-butyl 4-(2-bromoethyl)piperidine-1-carboxylate |
---|---|
Synonyms |
N-Boc-4-(2-bromoethyl)piperidine
4-(2-bromo-ethyl)-piperine-1-carboxylic acid tert-butyl ester 1BOC-4-BROMOETHYLPIPERIDINE 1-Bromo-2-(1-t-butoxycarbonyl-4-piperidyl)ethane 4-(2-bromo-ethyl)-piperidine-1-carboxylic acid tert-butyl ester |
Molecular Formula | C12H22BrNO2 |
---|---|
Molecular Weight | 292.21300 |
Exact Mass | 291.08300 |
PSA | 29.54000 |
LogP | 3.35640 |
HS Code | 2933399090 |
---|
~88% 169457-73-2 |
Literature: AstraZeneca AB; NPS PHARMACEUTICALS Patent: US2007/32469 A1, 2007 ; Location in patent: Page/Page column 46 ; US 20070032469 A1 |
~% 169457-73-2 |
Literature: Glaxo Group Limited Patent: US5861414 A1, 1999 ; |
~% 169457-73-2 |
Literature: ZIV, Ilan; Grimberg, Hagit Patent: US2011/294754 A1, 2011 ; |
~% 169457-73-2 |
Literature: ZIV, Ilan; Grimberg, Hagit Patent: US2011/294754 A1, 2011 ; |
Precursor 4 | |
---|---|
DownStream 2 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |